The purpose of this study is to learn about the effects of a study drug on decreasing the damage to the kidneys and see how safe the study drug is for patients with IgAN/IgAVN, pMN, or MCD/FSGS.
At each visit, you will meet with the study team and fill out questionnaires. You will also complete sample collections including home urine collection and blood draws in the clinic. The study medication will be taken weekly at home except for the days you have a study visit.
Amount varies by visit type ranging from $100 to $150 for visits
Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA
UNC Eastowne Medical Office Building
100 Eastowne Dr, Chapel Hill, NC 27514, USA
Amy Mottl
Medicine-Nephrology
Clinical or Medical
Interventional
Kidneys and Liver
25-1420
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
